Nacon Interactions
There are 502 drugs known to interact with Nacon (carbinoxamine / methscopolamine / pseudoephedrine), along with 27 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 23 are major, 458 are moderate, and 21 are minor.
- View all 502 medications that may interact with Nacon
- View Nacon alcohol/food interactions (2)
- View Nacon disease interactions (27)
Most frequently checked interactions
View interaction reports for Nacon (carbinoxamine / methscopolamine / pseudoephedrine) and the medicines listed below.
- Anoro Ellipta (umeclidinium / vilanterol)
- atorvastatin
- bisoprolol
- Centrum Silver Men's (multivitamin with minerals)
- clonazepam
- diphenhydramine
- gabapentin
- loratadine
- mometasone nasal
- nortriptyline
- omeprazole
- propranolol
- Senokot (senna)
- Spiriva Respimat (tiotropium)
- tamsulosin
- tramadol
- valsartan
- Xarelto (rivaroxaban)
- zolpidem
Nacon alcohol/food interactions
There are 2 alcohol/food interactions with Nacon (carbinoxamine / methscopolamine / pseudoephedrine).
Nacon disease interactions
There are 27 disease interactions with Nacon (carbinoxamine / methscopolamine / pseudoephedrine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiovascular disease
- cardiac disease
- tachycardia
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
More about Nacon (carbinoxamine / methscopolamine / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
